Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Tan

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Antiviral Research|February 23, 2020
Adoptive T-cell therapy for HBV-associated HCC and HBV infectionAnthony T Tan, Sophia Schreiber
Immunotherapy Advances|August 3, 2022
HBV-HCC treatment with mRNA electroporated HBV-TCR T cellsAnthony T Tan, Antonio Bertoletti
Clinical and Molecular Hepatology|October 11, 2024
Reply to correspondence on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting"Antonio Bertoletti, Anthony T Tan
Clinical and Molecular Hepatology|June 27, 2024
Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting"Antonio Bertoletti, Anthony T Tan
Seminars in Immunology|November 7, 2025
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectivenessShan He, Anthony T Tan, Antonio Bertoletti
The Journal of Clinical Investigation|December 15, 2021
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. ReplyAnthony T Tan, Nina Le Bert, Antonio Bertoletti
International Journal of Molecular Sciences|September 23, 2022
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue LocalizationAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Oxford Open Immunology|April 16, 2024
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective roleAntonio Bertoletti, Anthony T Tan, Nina Le Bert
Viruses|October 14, 2011
HBV-Specific Adaptive ImmunityAntonio Bertoletti, Anthony T Tan, Adam J Gehring
Immunity|September 1, 2022
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemicAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Antiviral Research|February 23, 2020
Adoptive T-cell therapy for HBV-associated HCC and HBV infectionAnthony T Tan, Sophia Schreiber
Immunotherapy Advances|August 3, 2022
HBV-HCC treatment with mRNA electroporated HBV-TCR T cellsAnthony T Tan, Antonio Bertoletti
Clinical and Molecular Hepatology|October 11, 2024
Reply to correspondence on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting"Antonio Bertoletti, Anthony T Tan
Clinical and Molecular Hepatology|June 27, 2024
Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting"Antonio Bertoletti, Anthony T Tan
Seminars in Immunology|November 7, 2025
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectivenessShan He, Anthony T Tan, Antonio Bertoletti
The Journal of Clinical Investigation|December 15, 2021
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. ReplyAnthony T Tan, Nina Le Bert, Antonio Bertoletti
International Journal of Molecular Sciences|September 23, 2022
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue LocalizationAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Oxford Open Immunology|April 16, 2024
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective roleAntonio Bertoletti, Anthony T Tan, Nina Le Bert
Viruses|October 14, 2011
HBV-Specific Adaptive ImmunityAntonio Bertoletti, Anthony T Tan, Adam J Gehring
Immunity|September 1, 2022
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemicAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Pageof 5